Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-27 @ 8:45 PM
Study NCT ID:
NCT05892068
Status:
RECRUITING
Last Update Posted:
2025-07-25
First Post:
2023-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-09
Start Date Type:
ACTUAL
Primary Completion Date:
2028-05-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-18
First Submit QC Date:
None
Study First Post Date:
2023-06-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-22
Last Update Post Date:
2025-07-25
Last Update Post Date Type:
ACTUAL